IDXG — Interpace Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSuper Stock

Annual balance sheet for Interpace Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K/A	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	2.32	2.77	3.06	4.83	3.5
Net Total Accounts Receivable
Net Total Receivables	10.3	8.03	6.16	5.03	4.98
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	16.5	14.1	12.2	12.2	10.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	10.7	11.7	10.4	2.92	2.65
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	51.5	45.7	38.4	16	13
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	17.3	18.2	15.7	14.3	17.5
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	29.8	28.2	34.3	32.5	28.2
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	21.7	17.5	4.12	-16.5	-15.1
Total Liabilities & Shareholders' Equity	51.5	45.7	38.4	16	13
Total Common Shares Outstanding
Total Preferred Shares Outstanding